Compare · KITT vs TMO
KITT vs TMO
Side-by-side comparison of Nauticus Robotics Inc. (KITT) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both KITT and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $197.88B, about 36573.0x KITT ($5.4M).
- Over the past year, KITT is down 99.0% and TMO is up 28.1% - TMO leads by 127.1 points.
- TMO has been more active in the news (9 items in the past 4 weeks vs 8 for KITT).
- TMO has more recent analyst coverage (25 ratings vs 1 for KITT).
- Company
- Nauticus Robotics Inc.
- Thermo Fisher Scientific Inc
- Price
- $0.80-0.01%
- $532.16-2.05%
- Market cap
- $5.4M
- $197.88B
- 1M return
- -42.86%
- +12.59%
- 1Y return
- -99.03%
- +28.12%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 8
- 9
- Recent ratings
- 1
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest KITT
- Nauticus Robotics Pursues Next Generation Ocean Sensing Infrastructure with Aquanaut® Platform
- Large owner Rcb Equities 1, Llc converted options into 555,556 shares and sold $65,761 worth of shares (32,539 units at $2.02), increasing direct ownership by 201% to 782,829 units (SEC Form 4)
- New insider Rcb Equities 1, Llc claimed ownership of 782,829 shares (SEC Form 3)
- SEC Form S-8 filed by Nauticus Robotics Inc.
- Nauticus Robotics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Nauticus Robotics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Nauticus Robotics, Inc. Announces Exchange Agreement to Reduce a Large Portion of its Debt and Increase Stockholders' Equity
- Amendment: SEC Form S-1/A filed by Nauticus Robotics Inc.
- Amendment: Nauticus Robotics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Nauticus Robotics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
Latest TMO
- Thermo Fisher Scientific Announces Quarterly Dividend
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Keith R. Alexandra
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- Bernstein resumed coverage on Thermo Fisher with a new price target
- SEC Form 11-K filed by Thermo Fisher Scientific Inc
- Piper Sandler initiated coverage on Thermo Fisher with a new price target